Publications by authors named "Siminder Kaur Atwal"

Claim this Profile
Z
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma.
Constantine S Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Siminder Kaur Atwal

Blood Adv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up.
Judith Trotman, Stephen Opat, David Gottlieb, David Simpson, Paula Marlton, Siminder Kaur Atwal

Blood· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis